|
Low-dose dopamine or nesiritide of no help in acute heart failure. |
 |
 |
|
Mayo Clinic: In the Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE-AHF) randomized 26-site trial in the U.S. and Canada, researchers analyzed data on 360 hospitalized acute heart failure patients with kidney dysfunction from September 2010 to March 2013. Compared to placebo, researchers found that neither dopamine nor nesiritide, when also used with diuretic (water pills) therapy, was better at increasing urine volume or improving levels of serum cystatin-C, an indicator of kidney function, at the end of a 72-hour treatment.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
